Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
Abstract Currently, there are no recommended alternative assays for HER2 cases deemed equivocal by immunohistochemistry and fluorescent in situ hybridization. Digital PCR (ddPCR), a highly accurate method to determine DNA copy number, could be a robust alternative for clinical HER2 diagnostics. HER2...
Guardado en:
Autores principales: | Yuefeng Wang, Julia Y. S. Tsang, Yongmei Cui, Ji Cui, Ying Lin, Songli Zhao, Patrick T. W. Law, Sai Yin Cheung, Enders K. O. Ng, Gary M. K. Tse, Zunfu Ke |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/781a188a1d1d475190ab60b6d48f3515 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Avisek Majumder, et al.
Publicado: (2021) -
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
por: Stenehjem DD, et al.
Publicado: (2014) -
Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.
por: Chantal C H J Kuijpers, et al.
Publicado: (2013) -
Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.
por: Boris Itkin, et al.
Publicado: (2021) -
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
por: Advani P, et al.
Publicado: (2015)